【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
• Phase III pipeline portfolio: Global CNS disorders therapeutics market
• Phase II pipeline portfolio: Global CNS disorders therapeutics market
• Phase I pipeline portfolio: Global CNS disorders therapeutics market
• Pre-clinical and discovery pipeline portfolio: Global CNS disorders therapeutics market
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by type of disease
• Global depression drugs market
• Global MS drugs market
• Global schizophrenia drugs market
• Global bipolar disorder therapeutics market
• Global AD drugs market
• Global epilepsy drugs market
• Global PD drugs market
PART 08: Geographical segmentation
• CNS disorders therapeutics market in Americas
• CNS disorders therapeutics market in EMEA
• CNS disorders therapeutics market in APAC
PART 09: Market drivers
• Special regulatory designations for CNS disorders
• New DMD approvals for AD, PD, and MS
• Development of novel therapeutics using innovative technologies
• High growth potential of mAbs
PART 10: Impact of drivers
PART 11: Market challenges
• High failure rates of late-stage products in clinical trials
• Growing use of non-invasive neuromodulation and seizure management devices
• Unavailability of standard diagnostic methods
• Increase in rehabilitation programs
• Social stigma associated with CNS diseases
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Popularity of me-too drugs
• Increased uptake of new-generation drugs
• Reformulation of marketed drugs
• Focus on regenerative therapies for CNS disorders
• Increase in use of LAI antipsychotics
PART 14: Vendor landscape0
• Competitive scenario0
• Key news3
• GlaxoSmithKline7
• Pfizer2
• Eli Lilly8
• Janssen Pharmaceuticals3
• Novartis8
• Other prominent vendors4
PART 15: Appendix4
• List of abbreviations4
PART 16: Explore Technavio6
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global CNS disorders therapeutics market snapshot
Exhibit 03: Impact of key customer segments on market 2015
Exhibit 04: Key buying criteria for CNS drugs 2015
Exhibit 05: Share of pipeline molecules in global CNS disorders therapeutics market
Exhibit 06: Prevalence of dementia in various regions (millions)
Exhibit 07: Revenues of top-selling CNS drugs (2013-2015)
Exhibit 08: Global CNS disorders therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 09: Global CNS disorders therapeutics market 2015-2020 ($ billions)
Exhibit 10: Impact of drivers and challenges on global CNS disorders therapeutics market
Exhibit 11: Five forces analysis
Exhibit 12: Global CNS disorders therapeutics market: Segmentation by application (2015-2020)
Exhibit 13: Global CNS disorders therapeutics market: Segmentation by type of disease 2015
Exhibit 14: Global CNS disorders therapeutics market segmentation: Growth cycle analysis
Exhibit 15: Global depression drugs market 2015-2020 ($ billions)
Exhibit 16: Opportunity analysis of global depression drugs market
Exhibit 17: Global MS drugs market 2015-2020 ($ billions)
Exhibit 18: Opportunity analysis of global MS drugs market
Exhibit 19: Global schizophrenia drugs market 2015-2020 ($ billions)
Exhibit 20: Opportunity analysis of global schizophrenia drugs market
Exhibit 21: Global bipolar disorder therapeutics market 2015-2020 ($ billions)
Exhibit 22: Opportunity analysis of global bipolar disorder therapeutics market
Exhibit 23: Population aged 60 years and above in millions (1950-2050)
Exhibit 24: Global AD drugs market 2015-2020 ($ billions)
Exhibit 25: Opportunity analysis of global AD drugs market
Exhibit 26: Global epilepsy drugs market 2015-2020 ($ billions)
Exhibit 27: Percentage share of marketed antiepileptic drugs based on mechanism of action
Exhibit 28: Opportunity analysis of global epilepsy drugs market
Exhibit 29: Global PD drugs market 2015-2020 ($ billions)
Exhibit 30: Opportunity analysis of global PD drugs market
Exhibit 31: Global CNS disorders therapeutics market: Geography outlook (2015-2020)
Exhibit 32: Global CNS disorders therapeutics market: Geography outlook 2015
Exhibit 33: Global CNS disorders therapeutics market segmentation by geography: Market growth lifecycle analysis 2015
Exhibit 34: Global CNS disorders market revenue/growth outlook in different countries/regions 2015
Exhibit 35: Global CNS disorders therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 36: Opportunity analysis of CNS disorders therapeutics market in Americas
Exhibit 37: Projected prevalence rates of AD in Americas (2010-2050) (millions)
Exhibit 38: CNS disorders therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 39: Percentage share of CNS disorders therapeutics market in Americas by geography 2015
Exhibit 40: Opportunity analysis of CNS disorders therapeutics market in EMEA
Exhibit 41: CNS disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 42: Opportunity analysis of CNS disorders therapeutics market in APAC
Exhibit 43: CNS disorders therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 44: Few of the late-stage mAbs under development for various CNS disorders
Exhibit 45: Impact of drivers
Exhibit 46: Common disorders that co-exist with bipolar disorder
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Impact of trends on global CNS disorders therapeutics market
Exhibit 49: Planned clinical trials of iPS cell-based therapies
Exhibit 50: Position of key vendors in the global CNS disorders therapeutics market 2015
Exhibit 51: Geographical presence of key vendors
Exhibit 52: Company portfolio analysis in global CNS disorders therapeutics market 2016-2020
Exhibit 53: GlaxoSmithKline: Profile
Exhibit 54: GlaxoSmithKline: Sales of top-selling CNS drugs ($ millions)
Exhibit 55: GlaxoSmithKline: Metrics analysis
Exhibit 56: GlaxoSmithKline: Growth strategy matrix
Exhibit 57: GlaxoSmithKline: Opportunity assessment
Exhibit 58: Pfizer: Profile
Exhibit 59: Sales of CNS drugs ($ millions)
Exhibit 60: Pfizer: Metrics analysis
Exhibit 61: Pfizer: Growth strategy matrix
Exhibit 62: Pfizer: Opportunity assessment
Exhibit 63: Eli Lilly: Profile
Exhibit 64: Eli Lilly: Sales of top-selling CNS drugs ($ millions)
Exhibit 65: Eli Lilly: Metrics analysis
Exhibit 66: Eli Lilly: Growth strategy matrix
Exhibit 67: Eli Lilly: Opportunity assessment
Exhibit 68: Janssen Pharmaceuticals: Profile
Exhibit 69: Janssen Pharmaceuticals: Sales of CNS drugs ($ millions)
Exhibit 70: Janssen Pharmaceuticals: Metrics analysis
Exhibit 71: Janssen Pharmaceuticals: Growth strategy matrix
Exhibit 72: Janssen Pharmaceuticals: Opportunity assessment
Exhibit 73: Novartis: Profile
Exhibit 74: Novartis: Sales of few major CNS drugs ($ millions)
Exhibit 75: Novartis: Metrics analysis
Exhibit 76: Novartis growth strategy matrix
Exhibit 77: Novartis: Opportunity assessment
【レポート販売概要】
■ タイトル：中枢神経系（CNS）障害治療薬の世界市場2016-2020■ 英文：Global Central Nervous System Disorders Therapeutics Market 2016-2020
■ 発行日：2016年9月22日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10192
■ 調査対象地域：グローバル
- デュシェンヌ型筋ジストロフィー治療薬の世界市場2015-2019About Duchenne muscular dystrophy Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The la …
- 世界のNAS市場動向（2012-2016）TechNavio's analysts forecast Global NAS market to grow at a CAGR of 21.58 percent over the period 2012-2016. One of the key factors contributing to this market growth is need for cheaper and efficient storage infrastructure. The Global NAS market has also been witnessing mixed adoption of storage components. However, increasing congestion of enterprise networks could pose a challenge to the growt …
- 熱可塑性複合材料の世界市場：製品別、エンドユーザー別、樹脂タイプ別、ファイバータイプ別、地域別Global Thermoplastic Composites Market: About this market Technavio’s thermoplastic composites market analysis considers sales from aerospace and defense, consumer goods and electronics, automotive, construction, wind energy, and other end-users. Our study also finds the sales of thermoplastic composites in APAC, Europe, MEA, North America, and South America. In 2019, the aerospace and defense seg …
- 世界の電気小型車市場（2007-2018）This latest just-auto report edition offers a global review of the electric vehicles sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Electric vehicles market size estimates Latest technologies and trends Profiles of the major players including their strategies and prospects Market size forecasts You can use this report to: Understand the …
- 足関節全置換：グローバル市場分析と予測MediPoint: Total Ankle Replacement - Global Analysis and Market Forecasts Summary Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly seeking out a modern lifestyle, sports-related injuries, trauma, aging, and obesity are contributing to an increased incidence of ankle arthritis. Total ankle rep …
- 無人貨物輸送機（UCA）システムの世界市場2016-2026The latest report from business intelligence provider visiongain offers comprehensive analysis of the global unmanned cargo aircraft market. Visiongain assesses that this market will generate revenues of US$474m in 2016. Have you heard the latest news? “Alphabet Inc. gets go-ahead to test Project Wing delivery drones at a US site”. This is an example of the business critical headline that you need …
- Levadex (片頭痛/Migraine)：医薬品市場予測及び分析（～2023）Levadex (Migraine) - Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products a …
- 自動ハンドルの世界市場2018-2022About Automated Steering Wheel An automotive steering system acts as a direct line of control and communication between the driver and the vehicle. It has evolved from involving rigid mechanisms to a more technologically advanced, reliable, smooth, and easy-to-use system. Technavio’s analysts forecast the global automated steering wheel market to grow at a CAGR of 41.61% during the period 2018-202 …
- Mycoplasma：医療検査市場2014The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- 医薬品卸売/流通の世界市場動向及び予測Pharma Wholesaling and Distribution – Now Gain Analysis of Companies, Trends and Revenues to Benefit Your Influence What does the future hold for drug wholesale and distribution (W&D) services? Discover revenue predictions there to 2025. And explore trends in those services and technologies, assessing prospects and finding opportunities to benefit your work and influence. In visiongain’s new repor …
- インターフェロンの世界市場及びパイプライン分析Interferons are small, low molecular weight proteins of varying sizes induced during attack by infectious agents like viruses. Investigators have found that they are highly variable in nature and have several subtypes due to which misunderstanding is easily created. Furthermore, they have synergistic effect in which interferons belonging to different classes have same effect on immune system due t …
- クールルーフコーティングの世界市場分析：製品別（エラストマー、IR反射）、用途別（スロースロープ、スティープスロープ）、エンドユーザー別（住宅、商業、工業用）、セグメント予測The global cool roof coating market is expected to reach USD 5.41 billion by 2025, according to a new report by Grand View Research, Inc. Favorable regulations to lower energy consumption are likely to be a major factor for rising popularity of cool roof coatings. Cool roof coatings help to reduce the heat buildup within the buildings, thus resulting in lower dependence on air conditioning. This c …
- 動物用画像診断装置の世界市場2015-2022According to Stratistics MRC, the Global Veterinary Imaging Market is valued at $1.98 billion in 2015 and is expected to grow at a CAGR of 7.1% to reach $3.21 billion by 2022. Increasing demand for diagnostic equipment for the appropriate care of pets is one of the key factors fueling the market growth. Moreover, shift towards oil drilling activities by exploration and production companies due to …
- 産業用ロボットの世界市場：関節ロボット、直角座標ロボット、SCARAロボット、円筒座標ロボット、パラレルロボットThe global industrial robotics market is expected to reach USD 79.58 Billion by 2022, growing at a CAGR of 11.92% between 2016 and 2022. The main drivers of this growth are the adoption of automation to ensure quality production and meet market demand as well as the growing demand from small- and medium-scale enterprises in developing countries. The maximum growth for industrial robotics is expect …
- コンピュータ支援コーディングソフトウェアの世界市場：自然言語処理ソフトウェア、構造化入力ソフトウェア、コーディングサービス、プログラムComputer-assisted coding has helped in reducing coding errors, thereby reducing healthcare costs and increasing the productivity of healthcare facilities globally. The global computer-assisted coding market is expected to grow at a CAGR of around 16% to 17% during the forecast period. This market is mainly driven by regulatory compliances, growing information content in healthcare organizations, a …
